Proposals for managing patients with thoracic malignancies during COVID-19 pandemic - 29/11/20

Doi : 10.1016/j.resmer.2020.100769

N. Girard ^a,^⁎ , L. Greillier ^b, G. Zalcman ^c, J. Cadranel ^d, D. Moro-Sibilot ^e, J. Mazières ^f, C. Audigier-Valette ^g, J. Bennouna ^h, B. Besse ⁱ, A. Cortot ^j, S. Couraud ^k, M. Duruisseaux ^k, E. Giroux-Leprieur ^l, A.-C. Toffart ^e, V. Westeel ^m, M. Wislez ⁿ
on behalf of the
French Language Society of Pulmonology SPLF French language Oncology Group
^a Department of Medical Oncology, Institut Curie, 75005 Paris, France
^b Aix-Marseille Université, AP–HM, INSERM, CNRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, 13915 Marseille, France
^c Department of Thoracic Oncology, CIC 1425, AP–HP, Hôpital Bichat–Claude-Bernard, 75018 Paris, France
^d Department of Thoracic Oncology, AP–HP, Hôpital Tenon, 75020 Paris, France
^e Department of Pneumology, University Hospital of Grenoble, 38043 Grenoble, France
^f Department of Pneumology, University Hospital of Toulouse, 31059 Toulouse, France
^g Department of Pneumology, Hôpital Sainte-Musse, 83100 Toulon, France
^h Department of Medical Oncology, University Hospital of Nantes, 44000 Nantes, France
ⁱ Department of Medical Oncology, Institut Gustave-Roussy, 94800 Villejuif, France
^j Department of Pneumology, University Hospital of Lille, 59000 Lille, France
^k Department of Pneumology and Thoracic Oncology, University Hospital of Lyon, 69002 Lyon, France
^l Department of Thoracic Oncology, AP–HP, Hôpital Ambroise-Paré, 92100 Boulogne-Billancourt, France
^m Department of Pneumology and Thoracic Oncology, University Hospital of Besançon, INSERM UMR 1098, Université de Franche-Comté, 25000 Besançon, France
ⁿ Department of Thoracic Oncology, AP–HP, Hôpital Cochin, Inserm UMR_S 1138, Université de Paris, 75014 Paris, France

^⁎Corresponding author. Institut du Thorax Curie Montsouris, Institut Curie, 26, rue d’Ulm, 75005 Paris, France.Institut du Thorax Curie Montsouris, Institut Curie26, rue d’UlmParis75005France

connettersi o creare un account

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

The objective of this document is to formalize a degraded mode management for patients with thoracic cancers in the context of the COVID-19 pandemic. The proposals are based on those of the French High Council for Public Health, on published data outside the context of COVID-19, and on a concerted analysis of the risk-benefit ratio for our patients by a panel of experts specialized on thoracic oncology under the aegis of the French-Language Society of Pulmonology (SPLF)/French-language oncology group. These proposals are evolving (10 April 2020) according to the situations encountered, which will enrich it, and are to be adapted to our institutional organisations and to the evolution of resources during the COVID-19 epidemic. Patients with symptoms and/or COVID-19+ are not discussed in this document and are managed within the framework of specific channels.

Il testo completo di questo articolo è disponibile in PDF.

Mappa

Introduction

General considerations and measures

Patient categories

Patients with non-small cell lung cancer in the surgical phase of care

Patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy

Patients with metastatic non-small cell lung cancer

Patients with small cell lung cancer

Patients with mesothelioma

Patient with thymic malignancies

Patients in clinical trials

Disclosure of interest

Esportazione

Vol 78

Articolo 100769- Novembre 2020 Ritorno al numero

Articolo precedente

Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases
C. Rabec, J. Gonzalez-Bermejo, Respiratory Support, Chronic Care Group GAVO 2 of the French Society of Respiratory Diseases SPLF, GAVO 2 collaborators, M. Mercy, L. Grassion, S. Pontier, M. Patout, R. Luque, C. Delafosse, C. Raherison-Semjen, B. Maître, L. Duthoit, A. Mendoza, L. Jacquin, J.C. Borel, P. Cervantes, J.-P. Janssens, J.-F. Chabot, C. Morelot-Panzini, D. Jaffuel

| Articolo seguente

Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience
C. Dupin, M. Hurtado, A. Cazes, C. Taille, M.P. Debray, C. Guenée, L. Tabeze, B. Crestani, R. Borie

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

connettersi o creare un account

Proposals for managing patients with thoracic malignancies during COVID-19 pandemic - 29/11/20

Abstract

Mappa

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL